These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9309700)

  • 21. Acquired immune and inflammatory myopathies: pathologic classification.
    Pestronk A
    Curr Opin Rheumatol; 2011 Nov; 23(6):595-604. PubMed ID: 21934500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolomes of mitochondrial diseases and inclusion body myositis patients: treatment targets and biomarkers.
    Buzkova J; Nikkanen J; Ahola S; Hakonen AH; Sevastianova K; Hovinen T; Yki-Järvinen H; Pietiläinen KH; Lönnqvist T; Velagapudi V; Carroll CJ; Suomalainen A
    EMBO Mol Med; 2018 Dec; 10(12):. PubMed ID: 30373890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Steroid-responsive inclusion body myositis associated with endometrial cancer.
    Alexandrescu DT; Bhagwati NS; Fomberstein B; Wolfe DE; Feliz A; Wiernik PH
    Clin Exp Rheumatol; 2005; 23(1):93-6. PubMed ID: 15789894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Histological data in inflammatory myositis].
    Mikol J; Polivka M
    Ann Med Interne (Paris); 2001 Nov; 152(7):465-79. PubMed ID: 11965088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Inclusion body myositis associated with sacroidosis: a report of 3 cases].
    Bouillot S; Coquet M; Ferrer X; Lagueny A; Leroy JP; Vital C
    Ann Pathol; 2001 Aug; 21(4):334-6. PubMed ID: 11685131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inclusion body myositis: clinical and pathological boundaries.
    Amato AA; Gronseth GS; Jackson CE; Wolfe GI; Katz JS; Bryan WW; Barohn RJ
    Ann Neurol; 1996 Oct; 40(4):581-6. PubMed ID: 8871577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inclusion body myositis--sensory dysfunction revealed with quantitative determination of somatosensory thresholds.
    Arnardottir S; Svanborg E; Borg K
    Acta Neurol Scand; 2003 Jul; 108(1):22-7. PubMed ID: 12807389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Inclusion body myositis. Report of 4 cases].
    Basquiera AL; Caeiro F; Palacio S; Theaux R; Casale A; Lucero C; Alvarellos A
    Medicina (B Aires); 2002; 62(1):37-40. PubMed ID: 11965848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Inclusion body myositis].
    Serratrice G
    Presse Med; 1996 Jun; 25(21):985-8. PubMed ID: 8692777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unravelling inclusion body myositis using a patient-derived fibroblast model.
    Cantó-Santos J; Valls-Roca L; Tobías E; García-García FJ; Guitart-Mampel M; Esteve-Codina A; Martín-Mur B; Casado M; Artuch R; Solsona-Vilarrasa E; Fernandez-Checa JC; García-Ruiz C; Rentero C; Enrich C; Moreno-Lozano PJ; Milisenda JC; Cardellach F; Grau-Junyent JM; Garrabou G
    J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):964-977. PubMed ID: 36860172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dermatomyositis with inclusion body myositis pathology.
    Layzer R; Lee HS; Iverson D; Margeta M
    Muscle Nerve; 2009 Sep; 40(3):469-71. PubMed ID: 19623629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Inclusion body myositis (IBM) -- a review].
    Czaplinski A; Renaud S; Fuhr P
    Praxis (Bern 1994); 2003 Apr; 92(14):649-54. PubMed ID: 12723314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Familial inflammatory inclusion body myositis.
    Ranque-Francois B; Maisonobe T; Dion E; Piette JC; Chauveheid MP; Amoura Z; Papo T
    Ann Rheum Dis; 2005 Apr; 64(4):634-7. PubMed ID: 15769920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inflammatory myopathies.
    Amato AA; Greenberg SA
    Continuum (Minneap Minn); 2013 Dec; 19(6 Muscle Disease):1615-33. PubMed ID: 24305450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myopathy associated with gluten sensitivity.
    Hadjivassiliou M; Chattopadhyay AK; Grünewald RA; Jarratt JA; Kandler RH; Rao DG; Sanders DS; Wharton SB; Davies-Jones GA
    Muscle Nerve; 2007 Apr; 35(4):443-50. PubMed ID: 17143894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intracellular phosphates in inclusion body myositis--a 31P magnetic resonance spectroscopy study.
    Argov Z; Taivassalo T; De Stefano N; Genge A; Karpati G; Arnold DL
    Muscle Nerve; 1998 Nov; 21(11):1523-5. PubMed ID: 9771678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proteomic analysis of inclusion body myositis.
    Li J; Yin C; Okamoto H; Jaffe H; Oldfield EH; Zhuang Z; Vortmeyer AO; Rushing EJ
    J Neuropathol Exp Neurol; 2006 Aug; 65(8):826-33. PubMed ID: 16896316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Shared blood and muscle CD8+ T-cell expansions in inclusion body myositis.
    Dimitri D; Benveniste O; Dubourg O; Maisonobe T; Eymard B; Amoura Z; Jean L; Tiev K; Piette JC; Klatzmann D; Herson S; Boyer O
    Brain; 2006 Apr; 129(Pt 4):986-95. PubMed ID: 16455793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Difference in adhesion molecule expression (ICAM-1 and VCAM-1) in juvenile and adult dermatomyositis, polymyositis and inclusion body myositis.
    Sallum AM; Kiss MH; Silva CA; Wakamatsu A; Vianna MA; Sachetti S; Marie SK
    Autoimmun Rev; 2006 Feb; 5(2):93-100. PubMed ID: 16431335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tau aggregates are abnormally phosphorylated in inclusion body myositis and have an immunoelectrophoretic profile distinct from other tauopathies.
    Maurage CA; Bussière T; Sergeant N; Ghesteem A; Figarella-Branger D; Ruchoux MM; Pellissier JF; Delacourte A
    Neuropathol Appl Neurobiol; 2004 Dec; 30(6):624-34. PubMed ID: 15541003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.